18 May 2013
Keywords: gsk, advair, diskus, approved, copd, exacerbations, fda
Article | 05 May 2008
The US Food and Drug Administration has approved UK drug major GlaxoSmithKline's Advair Diskus 250/50 (fluticasone propionate 250mcg
and salmeterol 50mcg ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2008
17 May 2013
© 2013 thepharmaletter.com